AIRLINK 74.20 Increased By ▲ 0.20 (0.27%)
BOP 5.03 Increased By ▲ 0.01 (0.2%)
CNERGY 4.44 Increased By ▲ 0.02 (0.45%)
DFML 39.14 Decreased By ▼ -0.06 (-0.15%)
DGKC 86.20 Increased By ▲ 0.11 (0.13%)
FCCL 21.70 Increased By ▲ 0.05 (0.23%)
FFBL 34.34 Increased By ▲ 0.33 (0.97%)
FFL 9.90 Decreased By ▼ -0.02 (-0.2%)
GGL 10.61 Increased By ▲ 0.05 (0.47%)
HBL 113.65 Decreased By ▼ -0.24 (-0.21%)
HUBC 135.85 Increased By ▲ 0.01 (0.01%)
HUMNL 11.72 Decreased By ▼ -0.18 (-1.51%)
KEL 4.82 Decreased By ▼ -0.02 (-0.41%)
KOSM 4.60 Increased By ▲ 0.07 (1.55%)
MLCF 38.35 Increased By ▲ 0.08 (0.21%)
OGDC 134.90 Increased By ▲ 0.05 (0.04%)
PAEL 26.65 Increased By ▲ 0.30 (1.14%)
PIAA 19.24 Decreased By ▼ -1.56 (-7.5%)
PIBTL 6.77 Increased By ▲ 0.09 (1.35%)
PPL 122.65 Decreased By ▼ -0.35 (-0.28%)
PRL 27.32 Increased By ▲ 0.63 (2.36%)
PTC 14.41 Increased By ▲ 0.08 (0.56%)
SEARL 59.00 Decreased By ▼ -0.12 (-0.2%)
SNGP 69.25 Decreased By ▼ -0.25 (-0.36%)
SSGC 10.35 Increased By ▲ 0.02 (0.19%)
TELE 8.53 Increased By ▲ 0.03 (0.35%)
TPLP 11.19 Decreased By ▼ -0.04 (-0.36%)
TRG 64.85 No Change ▼ 0.00 (0%)
UNITY 26.30 Increased By ▲ 0.05 (0.19%)
WTL 1.34 No Change ▼ 0.00 (0%)
BR100 7,858 Increased By 7.4 (0.09%)
BR30 25,326 Decreased By -10.9 (-0.04%)
KSE100 75,349 Increased By 142.5 (0.19%)
KSE30 24,172 Increased By 29.6 (0.12%)

GENEVA: The World Health Organization's vaccine advisers on Monday recommended people with weaker immune systems should be offered an additional dose of all authorised Covid-19 vaccines.

The UN health agency's Strategic Advisory Group of Experts on Immunisation (SAGE) also said over-60s who have been fully immunised with China's Sinovac and Sinopharm vaccine should be offered an additional third Covid-19 vaccine dose.

The experts stressed they were not recommending an additional so-called booster dose for the population at large.

Several Covid-19 vaccines have been given WHO approval for emergency use during the pandemic: Pfizer-BioNTech, Janssen, Moderna, Sinopharm, Sinovac and AstraZeneca.

AstraZeneca antibody drug important as preventative COVID-19 therapy

It is on the verge of deciding whether to give emergency use listing to India's Bharat Biotech jab.

SAGE held a four-day meeting last week to review the latest information and data on a range of vaccines for Covid-19 and other diseases.

"SAGE recommended that moderately and severely immunocompromised persons should be offered an additional dose of all WHO EUL (emergency use listing) Covid-19 vaccines as part of an extended primary series," the group said.

"These individuals are less likely to respond adequately to vaccination following a standard primary vaccine series and are at high risk of severe Covid-19 disease."

It also said that for people fully immunised with Sinovac and Sinopharm vaccines, an additional third dose of the same jab "should be offered to persons aged 60 and above".

A different vaccine "may also be considered based on vaccine supply and access considerations".

SAGE added that when implementing this recommendation, countries should initially aim at maximising two-dose coverage in that population, and thereafter administer the third dose, starting in the oldest age groups.

Comments

Comments are closed.